Clinical Trial Update: Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression [Phase 1]

View source ↗

Summary

This Phase 1 trial investigates whether gamma oscillations can predict response to ketamine therapy in treatment-resistant depression. The study is currently su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Texas A&M University | Conditions: Healthy, Major Depressive Disorder | Phase 1 | Status: SUSPENDED